July 6, 2020
July 4, 2020
Let’s remember, the USDA should never have awarded a $39 million contract to CRE8AD8, a San Antonio event planner we wouldn’t entrust with putting tchotchkes in a bag, let alone delivering food for struggling families.
July 2, 2020
Washington, D.C. – As this pandemic wreaks catastrophic unemployment and millions struggle to pay rent—and yet corporate lobbyists press for more windfalls—U.S. Representative Lloyd Doggett (TX) and Senator Sherrod Brown (OH) were joined by Sen. Whitehouse (RI), and Reps. DeLauro (CT) and Cohen (TN) in leading over 100 lawmakers to urge House and Senate leaders to reject wasteful corporate tax breaks in the next relief legislation, and instead work to provide assistance directly to those who need it most.
June 29, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, released the following statement regarding Gilead’s announcement this morning that it will charge about $3,120 for a treatment course of remdesivir per patient with commercial insurance in the United States:
June 24, 2020
WASHINGTON – U.S. Senator Dick Durbin (D-IL) and U.S. Representative Lloyd Doggett (D-TX-35) today introduced the American Assistance for American Companies Act¸ a bill to ensure that inverted corporations cannot benefit from federal COVID-19 financial assistance under the Coronavirus Aid, Relief, and Economic Security (CARES) Act. For years, the tax inversion loophole has allowed large multinational corporations to do a paper shift of their corporate citizenship from the United States to a low-tax foreign jurisdiction, while keeping their executives and headquarters here in America. Unfortunately, these corporations, which have skirted their U.S. tax obligations for years, may still qualify for federal assistance under the CARES Act.
WASHINGTON, DC - Today, Congressman Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee; Congresswoman Jan Schakowsky (D-IL), a Senior Chief Deputy Whip and Chair of the Energy and Commerce Consumer Protection and Commerce Subcommittee; Congressman Francis Rooney (R-FL); Congresswoman Rosa DeLauro (D-CT), Chair of the House Appropriations Labor-HHS Subcommittee; and Congressman Peter DeFazio (D-OR), Chair of the Transportation and Infrastructure Committee, introduced two pieces of bipartisan legislation to protect patients from being price-gouged on COVID-19 treatments and vaccines developed with taxpayer dollars and to strengthen oversight of federal funds invested in COVID-19 research and development.
June 21, 2020
For more than 100,000 young Texans, many of whom only know the U.S. as home, the recent 5-4 Supreme Court decision blocking President Donald Trump from ending the Deferred Action for Childhood Arrivals program (DACA) was cause for celebration —welcome news amid the struggle to protect Black lives and the harsh strain of the pandemic and the related economic crisis. But, importantly, this ruling represents a reprieve, not a resolution, of the problem Trump created.
June 18, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, released the following statement regarding the Supreme Court’s decision this morning to block President Trump’s attempt to end the Deferred Action for Childhood Arrivals (DACA) program:
A nursing home deep on San Antonio’s South Side appears to have received $9.3 million in federal bailout funds meant to go to medical providers serving on the front lines of the coronavirus pandemic. Hunters Pond Rehabilitation and Healthcare Center recently reported getting the funds from the Coronavirus Aid, Relief, and Economics Security Act and other federal programs.
June 8, 2020
The US government's current supply of remdesivir, the only drug known to work against Covid-19, will run out at the end of the month, Dr. Robert Kadlec, a US Department of Health and Human Services official, told CNN.